Literature DB >> 24010825

Emerging roles for immunomodulatory functions of free ISG15.

Jessica A Campbell1, Deborah J Lenschow.   

Abstract

Type I interferons (IFNs) exert their effects through the induction of hundreds of IFN-stimulated genes (ISGs), many of which function by inhibiting viral replication and modulating immune responses. ISG15, a di-ubiquitin-like protein, is one of the most abundantly induced ISGs and is critical for control of certain viral and bacterial infections. Like ubiquitin, ISG15 is covalently conjugated to target proteins. In addition, free unconjugated ISG15 is present both intra- and extracellularly. Although much remains to be learned about conjugated ISG15, even less is known about the 2 free forms of ISG15. This article focuses on the role that ISG15 plays during the host response to pathogen challenge, in particular on the recent observations describing the immunomodulatory properties of free ISG15 and its potential implication in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010825      PMCID: PMC3868375          DOI: 10.1089/jir.2013.0064

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  87 in total

1.  Small ubiquitin-related modifier is secreted and shows cytokine-like activity.

Authors:  Hidetaka Hosono; Hideyoshi Yokosawa
Journal:  Biol Pharm Bull       Date:  2008-05       Impact factor: 2.233

2.  Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein.

Authors:  J L Potter; J Narasimhan; L Mende-Mueller; A L Haas
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

3.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin.

Authors:  Weiguo Zou; Vladimir Papov; Oxana Malakhova; Keun Il Kim; Chinh Dao; Jun Li; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

5.  Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification.

Authors:  He-Xin Shi; Kai Yang; Xing Liu; Xin-Yi Liu; Bo Wei; Yu-Fei Shan; Lian-Hui Zhu; Chen Wang
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

6.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

7.  Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor.

Authors:  Makoto Owhashi; Yasuki Taoka; Kazunari Ishii; Shusuke Nakazawa; Haruki Uemura; Hiroji Kambara
Journal:  Biochem Biophys Res Commun       Date:  2003-09-26       Impact factor: 3.575

8.  Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Authors:  Min-Jung Kim; Sun-Young Hwang; Tadaatsu Imaizumi; Joo-Yeon Yoo
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

9.  Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection.

Authors:  Caroline Lai; Jessica J Struckhoff; Jana Schneider; Luis Martinez-Sobrido; Thorsten Wolff; Adolfo García-Sastre; Dong-Er Zhang; Deborah J Lenschow
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

10.  HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells.

Authors:  Diede Oudshoorn; Sander van Boheemen; Maria Teresa Sánchez-Aparicio; Ricardo Rajsbaum; Adolfo García-Sastre; Gijs A Versteeg
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more
  18 in total

Review 1.  How ISG15 combats viral infection.

Authors:  Brendan T Freitas; Florine E M Scholte; Éric Bergeron; Scott D Pegan
Journal:  Virus Res       Date:  2020-05-31       Impact factor: 3.303

Review 2.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

3.  ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Authors:  Ziying Han; Cari A Sagum; Mark T Bedford; Sachdev S Sidhu; Marius Sudol; Ronald N Harty
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

4.  Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.

Authors:  Daniel O Villarreal; Megan C Wise; Rebekah J Siefert; Jian Yan; Laurence M Wood; David B Weiner
Journal:  Mol Ther       Date:  2015-06-30       Impact factor: 11.454

Review 5.  Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).

Authors:  Inbar Magid Gold; Noa Reis; Fabian Glaser; Michael H Glickman
Journal:  Semin Cell Dev Biol       Date:  2022-06-25       Impact factor: 7.499

6.  Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.

Authors:  Carmen Elena Gómez; Beatriz Perdiguero; Michela Falqui; María Q Marín; Martina Bécares; Carlos Óscar S Sorzano; Juan García-Arriaza; Mariano Esteban; Susana Guerra
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

7.  ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.

Authors:  Rubén González-Sanz; Manuel Mata; Jesús Bermejo-Martín; Amparo Álvarez; Julio Cortijo; José A Melero; Isidoro Martínez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 8.  Post-translational add-ons mark the path in exosomal protein sorting.

Authors:  Olga Moreno-Gonzalo; Irene Fernandez-Delgado; Francisco Sanchez-Madrid
Journal:  Cell Mol Life Sci       Date:  2017-10-27       Impact factor: 9.261

9.  Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.

Authors:  Julian Burks; Ryan E Reed; Shyamal D Desai
Journal:  Oncotarget       Date:  2015-03-30

10.  Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase.

Authors:  Patricia Domingues; Connor G G Bamford; Chris Boutell; John McLauchlan
Journal:  J Gen Virol       Date:  2015-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.